Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05282368
Other study ID # SON-2019-27260
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date March 1, 2023

Study information

Verified date April 2023
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test and evaluate the Preparing Heart and Mind™ (PHM™) patient engagement pathway as a nurse-guided intervention to lower psychological distress and enhance caregiving competencies among mothers/birthing persons and their caregiving partners after a major fetal anomaly diagnosis.


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date March 1, 2023
Est. primary completion date March 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - A study participant can include a pregnant person past 20 weeks of pregnancy (this includes a vulnerable population) - Willing and able to comply with study procedures. - Participants must be = 18 years old. - Participants must be able to read, write and speak English. - Participants must have access, and ability to use a smartphone, tablet, or computer in a private location. - The pregnant woman/person and her caregiving partner are planning for infant delivery and care. - The fetal diagnosis of the major anomaly affects the heart (i.e., CCHD). See definition of CCHD included earlier in the protocol. Other anomalies could be present and potentially impair other organs. - The infant's anomaly will likely require surgical and/or medical intervention within the first year of life. - The fetus/infant is expected to live with surgical and/or medical intervention (this includes a vulnerable population). - There may be genetic and/or chromosomal conditions in addition to the heart/structural anomalies Exclusion Criteria: - Pregnancy termination - The fetal anomaly diagnosis is highly likely to result in fetal or infant demise shortly after birth. - Adults lacking the capacity to consent - Adults who do not have access to a smart phone, tablet, or device. - Caregiving partner cannot enroll if mother is not enrolled

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
PHM™ Pathway
The technological platform referred to as Preparing Heart and Mind™ (PHM™) is designed as a patient engagement pathway. This platform includes GetWellNetwork's proprietary workflow engine, Patient Pathways™ and functionality of the Health Loop platform. Specifically, PHM™ will be created on a customized GetWellNetwork patient engagement pathway, getwell | Loop, which is a secure platform with a parent-facing app and an interactive dashboard for healthcare providers. The PHM™ getwell | Loop is a care program with chapters that incorporate interactive resources for patient information and education, trackers as touch points for psycho-social/educational support, and tailors care with condition-specific content, as well as action items.

Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in State-Trait Anxiety Inventory score State subscale, 20 items, 4-point scale; State Anxiety cut point score =40 12 weeks after birth
Primary Change in Center for Epidemiology Scale-Depression (CES-D) score 20 items, 4-point scale; cut point score =16 12 weeks after birth
Primary Change in Impact of Event Scale score 22 items, 4-point scale; cut point score = 24 12 weeks after birth
See also
  Status Clinical Trial Phase
Recruiting NCT06046989 - Building Emotional Awareness and Mental Health in Parenting (BEAM) N/A
Terminated NCT01777724 - Evaluation of a Parenting and Stress Management Programmme N/A